月経前症候群（PMS）および月経ヘルスサプリメント市場- 世界の産業規模、シェア、動向、機会、予測、セグメント、製品タイプ別、適応症別、製剤別、最終用途別、地域別、競合、2020年～2030年

月経前症候群（PMS）および月経ヘルスサプリメントの世界市場は、2024年には205億8,000万米ドルと評価され、予測期間中のCAGRは5.25%で、2030年には280億4,000万米ドルに達すると予測されています。

月経前症候群（PMS）および月経ヘルスサプリメントの世界市場は、女性の健康問題に対する意識の高まりと、PMS症状を緩和するための自然で効果的な治療薬に対する需要の高まりにより、近年著しい成長を遂げています。この市場には、月経周期に伴う腹部膨満感、気分の落ち込み、けいれん、疲労などの症状を管理するために設計されたビタミン、ミネラル、ハーブサプリメント、その他の栄養補助食品など、幅広い製品が含まれています。栄養補助食品が広く受け入れられ、予防ヘルスケアの動向も成長を後押ししています。市場拡大の主な要因としては、ヘルスケア・インフラの発展、研究開発活動の活発化、これらの製品へのアクセスを容易にするeコマース・プラットフォームの影響力の拡大などが挙げられます。NIHのデータによると、女性の20％が日常生活に支障をきたすほど重い症状を経験し、残りの80％は軽度から中等度の症状です。エジプトで行われた研究では、PMSと甘いもの過剰摂取との間に関連性があることがわかり、PMSにおける生活習慣要因の重要な役割が浮き彫りになった。さらに、黄体期治療に対する理解が深まっていることも、市場拡大の重要な要因となっています。

ヘルスケア専門家による月経健康サプリメントの推奨とメーカーによるマーケティング活動の急増により、製品の認知度と消費者の信頼が大幅に高まっています。地域別分析によると、北米と欧州が健康意識と可処分所得の高さから最大の市場シェアを占めています。しかし、アジア太平洋地域は、人口の多さ、健康意識の高まり、可処分所得の増加により、最も速い成長が見込まれています。同市場の注目すべきプレーヤーは、製品の技術革新に注力し、有機・非遺伝子組み換え原料を取り入れ、多様な消費者ニーズに応えるべく製品ラインを拡大しています。戦略的提携、合併、買収は、市場での存在感を高め、成長を促進するために採用される一般的な戦略です。前向きな見通しとは裏腹に、規制上のハードルやサプリメントの効能を科学的に検証する必要性といった課題は依然として残っています。

主要市場促進要因

女性の健康問題に対する意識の高まり

予防ヘルスケアへのシフト

ヘルスケア・インフラの進歩

主な市場課題

規制上のハードル

科学的検証と有効性

消費者の誤った情報と偏見

主な市場動向

eコマースの影響力の増大

ナチュラル・オーガニック・サプリメントの台頭

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の月経前症候群（PMS）および月経ヘルスサプリメント市場の見通し

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別（複合栄養補助食品、単一栄養補助食品）
  • 適応症別（更年期障害、月経前症候群）
  • 製剤別（カプセル/錠剤、粉末、ソフトジェル、その他）
  • 用途別（薬局・ドラッグストア、オンライン販売チャネル、直販チャネル、その他）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米の月経前症候群（PMS）および月経ヘルスサプリメント市場の見通し

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別
  • 適応症別
  • 製剤別
  • 最終用途別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州月経前症候群（PMS）および月経ヘルスサプリメント市場の見通し

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別
  • 適応症別
  • 製剤別
  • 最終用途別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋の月経前症候群（PMS）および月経ヘルスサプリメント市場の見通し

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別
  • 適応症別
  • 製剤別
  • 最終用途別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の月経前症候群（PMS）および月経ヘルスサプリメント市場の見通し

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別
  • 適応症別
  • 製剤別
  • 最終用途別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東およびアフリカの月経前症候群（PMS）および月経ヘルスサプリメント市場の見通し

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別
  • 適応症別
  • 製剤別
  • 最終用途別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併および買収（該当する場合）
• 製品の発売（該当する場合）
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Herbalife International of America, Inc.
• Nature's Bounty
• Amway Corp.
• GNC Holdings, LLC
• USANA Health Sciences, Inc
• GlaxoSmithKline Plc
• MetP Pharma AG
• Archer-Daniels-Midland Company
• Power Gummies
• Looni

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market was valued at USD 20.58 Billion in 2024 and is expected to reach USD 28.04 Billion by 2030 with a CAGR of 5.25% during the forecast period. The Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market has witnessed significant growth in recent years, driven by increasing awareness of women's health issues and the rising demand for natural and effective remedies to alleviate PMS symptoms. This market encompasses a wide range of products, including vitamins, minerals, herbal supplements, and other nutritional aids designed to manage symptoms such as bloating, mood swings, cramps, and fatigue associated with the menstrual cycle. The growth is further fueled by the broader acceptance of dietary supplements and the trend towards preventive healthcare. Key factors contributing to the market expansion include advancements in healthcare infrastructure, increased research and development activities, and the growing influence of e-commerce platforms that provide easier access to these products. According to NIH data, 20% of women experience symptoms severe enough to disrupt their daily activities, while the remaining 80% have mild to moderate symptoms. A study from Egypt found a link between PMS and the consumption of excessive sugary foods, highlighting the significant role of lifestyle factors in PMS. Additionally, the growing understanding of luteal phase therapy is a key factor driving the market's expansion.

The endorsement of menstrual health supplements by healthcare professionals and the surge in marketing efforts by manufacturers are significantly boosting product visibility and consumer trust. Regional analysis indicates that North America and Europe hold the largest market shares due to high levels of health consciousness and disposable income. However, the Asia-Pacific region is expected to exhibit the fastest growth, attributed to its large population base, rising health awareness, and increasing disposable incomes. Notable players in the market are focusing on product innovation, incorporating organic and non-GMO ingredients, and expanding their product lines to cater to diverse consumer needs. Strategic collaborations, mergers, and acquisitions are common strategies employed to enhance market presence and drive growth. Despite the positive outlook, challenges such as regulatory hurdles and the need for scientific validation of supplement efficacy persist.

Key Market Drivers

Increasing Awareness of Women's Health Issues

Increasing awareness of women's health issues is a significant driver boosting the Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market. Over the past decade, there has been a remarkable shift in how society perceives and discusses women's health, particularly in the realm of menstrual health. This growing awareness can be attributed to several factors, including public health campaigns, educational initiatives, and the widespread dissemination of information through digital platforms. A 2021 report by the NIH highlighted that some women experienced missed or irregular menstrual cycles, heavier-than-usual bleeding, and other menstrual issues after receiving COVID-19 vaccines. This has contributed to the rise of menstrual supplements in the market, positioning COVID-19 as a driving force behind this trend. However, the growing demand for immune health supplements and the increased focus on combating COVID-19 has somewhat led to a decline in the demand for PMS supplements.

Public health campaigns have played a pivotal role in raising awareness about PMS and menstrual health. Governments and non-profit organizations worldwide have launched various initiatives to educate women about managing PMS symptoms effectively. These campaigns often highlight the importance of a balanced diet, regular exercise, and the use of supplements to alleviate symptoms like mood swings, bloating, and cramps. Educational initiatives, particularly in schools and workplaces, have also contributed to this heightened awareness. Comprehensive sex education programs now include detailed information about menstrual health, empowering young women with the knowledge they need to manage their menstrual cycles proactively. Employers, too, are increasingly recognizing the importance of supporting female employees by providing access to menstrual health resources and promoting a workplace culture that is open and supportive of discussing menstrual health.

Digital platforms, including social media and health-focused websites, have revolutionized the dissemination of information. Influencers and health professionals use these platforms to share personal experiences, tips, and product recommendations, making it easier for women to learn about and access menstrual health supplements. This digital revolution has normalized conversations around menstrual health, reducing the stigma and encouraging women to seek solutions for their PMS symptoms. As awareness continues to grow, so does the demand for effective and natural remedies. Women are becoming more proactive in managing their health, leading to increased consumption of menstrual health supplements. This trend is a key factor driving the robust growth of the Global PMS and Menstrual Health Supplements Market.

Shift Towards Preventive Healthcare

The shift towards preventive healthcare is significantly boosting the Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market. This paradigm shift reflects a broader change in consumer attitudes, as people increasingly prioritize maintaining their health and preventing illnesses rather than merely treating symptoms after they arise. This proactive approach is especially pertinent in the context of menstrual health, where managing PMS symptoms through preventive measures is becoming more popular.

Preventive healthcare emphasizes the importance of maintaining overall wellness through lifestyle choices, including diet, exercise, and the use of dietary supplements. For women, this approach translates into the regular use of menstrual health supplements to mitigate the impact of PMS. These supplements often contain a blend of vitamins, minerals, and herbal extracts that are designed to balance hormones, reduce inflammation, and improve mood. By incorporating these supplements into their daily routine, women can potentially prevent the severity of PMS symptoms before they occur, leading to a more manageable menstrual cycle.

The growing consumer preference for natural and holistic health solutions also drives the demand for menstrual health supplements. Unlike pharmaceutical treatments, which often come with side effects, these supplements are seen as a safer, more natural way to maintain hormonal balance and overall well-being. This trend towards natural health solutions aligns with the preventive healthcare model, further fueling market growth.

The increased focus on preventive healthcare is supported by healthcare professionals who now often recommend dietary supplements as part of a comprehensive health management plan. This professional endorsement lends credibility to the use of these products and encourages more women to adopt preventive measures for managing their menstrual health.

Advancements in Healthcare Infrastructure

Advancements in healthcare infrastructure are significantly boosting the Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market. Enhanced healthcare infrastructure includes improvements in medical facilities, distribution networks, technological innovations, and regulatory frameworks, all of which collectively contribute to greater accessibility and effectiveness of PMS and menstrual health supplements.

Improved medical facilities and healthcare services have made it easier for women to seek advice and treatment for menstrual health issues. Modern clinics and hospitals equipped with advanced diagnostic tools enable healthcare providers to offer personalized health recommendations, including the use of supplements for PMS management. This increased access to professional healthcare advice fosters a greater understanding of the benefits of menstrual health supplements, driving consumer demand.

Distribution networks have also seen significant advancements, ensuring that menstrual health supplements are readily available to a broader audience. Pharmacies, health food stores, and supermarkets now stock a wide range of supplements, making them easily accessible. The rise of e-commerce has revolutionized how consumers purchase health products. Online platforms offer an extensive selection of supplements, competitive pricing, and the convenience of home delivery, expanding the market reach and making these products accessible even in remote areas.

Technological innovations play a crucial role in the development and efficacy of menstrual health supplements. Advances in biotechnology and nutraceuticals have led to the creation of more effective and targeted formulations. These innovations include the use of high-quality, bioavailable ingredients that ensure better absorption and effectiveness. Continuous research and development efforts result in products that are scientifically validated, enhancing consumer trust and satisfaction.

Key Market Challenges

Regulatory Hurdles

Regulatory hurdles present a significant challenge to the Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market. Different countries have varying regulations concerning the formulation, labeling, and marketing of dietary supplements. These regulations can be complex and difficult to navigate, often requiring substantial investment in compliance and certification processes. For instance, the European Union has stringent regulations on health claims and the use of specific ingredients in supplements, which can delay product launches and increase costs for manufacturers. In the United States, the FDA's regulations under the Dietary Supplement Health and Education Act (DSHEA) necessitate rigorous quality control and accurate labeling, adding another layer of compliance requirements. This regulatory complexity can act as a barrier to market entry, especially for small and medium-sized enterprises that may lack the resources to meet these stringent requirements. Inconsistencies in regulations across different regions can create confusion and operational inefficiencies, hindering the global expansion of PMS and menstrual health supplement products. Navigating these regulatory landscapes requires substantial expertise and financial resources, posing a significant challenge to the growth and innovation within the market.

Scientific Validation and Efficacy

Ensuring the scientific validation and efficacy of PMS and menstrual health supplements is another critical challenge. Consumers are becoming increasingly skeptical and demand evidence-based products that guarantee safety and effectiveness. However, conducting rigorous clinical trials and obtaining scientific validation is both time-consuming and costly. Many supplements currently available lack robust scientific backing, which can undermine consumer trust and impede market growth. The dietary supplement industry often faces scrutiny due to instances of false health claims and the proliferation of low-quality products. To address these concerns, companies must invest in comprehensive research and development to substantiate their product claims with credible scientific data. This requires collaboration with medical professionals and research institutions to design and execute well-structured clinical trials. Ongoing post-market surveillance is necessary to monitor the long-term safety and effectiveness of these supplements. The challenge lies in balancing the need for scientific validation with the commercial pressures of bringing products to market swiftly. Failing to provide scientifically validated products can lead to regulatory actions, negative publicity, and a loss of consumer confidence, significantly hindering the growth of the PMS and menstrual health supplements market.

Consumer Misinformation and Stigma

Consumer misinformation and stigma surrounding PMS and menstrual health present significant obstacles to market growth. Despite increasing awareness, misconceptions and lack of knowledge about PMS and the benefits of menstrual health supplements persist. Many consumers remain skeptical about the efficacy of supplements, often due to misinformation or previous negative experiences with ineffective products. This skepticism is exacerbated by the stigma surrounding menstrual health, which can prevent open discussions and limit the dissemination of accurate information. Overcoming this challenge requires robust consumer education efforts that highlight the scientific basis and benefits of supplements. Companies need to invest in clear, transparent communication strategies to build trust and educate consumers. Social media campaigns, collaborations with healthcare professionals, and informative content can help dispel myths and reduce stigma. Leveraging influencers and testimonials from satisfied customers can enhance credibility and encourage more women to consider supplements as a viable option for managing PMS. Addressing consumer misinformation and stigma is crucial for fostering a supportive environment where women feel confident in seeking and using menstrual health supplements, thereby driving market growth.

Key Market Trends

Growing Influence of E-Commerce

The growing influence of e-commerce is a significant driver boosting the Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market. E-commerce platforms have revolutionized the way consumers purchase health and wellness products, including menstrual health supplements, by offering convenience, accessibility, and a wide selection of products. One of the key advantages of e-commerce is the convenience it provides to consumers. With just a few clicks, individuals can browse through an extensive range of menstrual health supplements from the comfort of their homes or on-the-go via mobile devices. This convenience eliminates the need to visit physical stores, saving time and effort for consumers with busy lifestyles. E-commerce platforms operate 24/7, allowing consumers to shop for supplements at their convenience, regardless of their location or time zone. In August 2022, Balance Beam Mood Complex, a menstrual health supplement by US-based Looni, is launching to address a "critical gray area" in women's health awareness. These vegan capsules are designed to stabilize hormones, reduce mood swings and cravings, and alleviate irritability.

Accessibility is another crucial factor driving the influence of e-commerce in the menstrual health supplements market. E-commerce platforms transcend geographical boundaries, making these products accessible to consumers worldwide. This is particularly beneficial for individuals residing in remote areas or regions with limited access to brick-and-mortar stores. E-commerce platforms often offer international shipping options, enabling consumers to purchase supplements from reputable brands regardless of their location.

E-commerce platforms also provide a wealth of information to consumers, empowering them to make informed purchasing decisions. Detailed product descriptions, customer reviews, and ratings help consumers evaluate the efficacy, safety, and quality of menstrual health supplements before making a purchase. E-commerce platforms often feature educational content and resources related to women's health, further raising awareness about PMS and the benefits of using supplements for menstrual health management.

The competitive pricing offered by e-commerce platforms makes menstrual health supplements more affordable and accessible to a wider audience. Online retailers frequently run promotions, discounts, and special offers, allowing consumers to purchase supplements at discounted prices. This price competitiveness encourages consumers to explore different brands and products, driving market growth and competition.

Rise of Natural and Organic Supplements

The rise of natural and organic supplements is a significant trend boosting the Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market. This shift is driven by an increasing consumer preference for health products that are perceived as safer and more holistic compared to synthetic alternatives. Women are becoming more health-conscious and selective about what they consume, seeking out natural and organic options to manage PMS symptoms without the side effects often associated with pharmaceutical treatments. In October 2022, Health & Her Ltd launched its first live culture supplements, specially formulated without phytoestrogens, targeting individuals going through perimenopause and menopause.

Natural supplements typically contain ingredients like chasteberry, evening primrose oil, magnesium, and vitamin B6, which have been traditionally used to alleviate PMS symptoms such as mood swings, cramps, bloating, and fatigue. These ingredients are favored for their perceived safety and efficacy, appealing to consumers who prioritize a natural approach to health and wellness. Organic supplements, free from pesticides, GMOs, and synthetic additives, further attract those concerned about environmental sustainability and the purity of the products they use.

The demand for natural and organic supplements has prompted companies to innovate and expand their product lines. Manufacturers are developing new formulations and delivery methods, such as gummies, powders, and capsules, to cater to diverse consumer preferences. Brands are investing in certifications like USDA Organic and Non-GMO Project Verified to enhance their credibility and appeal.

This trend is also supported by increased transparency and education. Consumers have access to vast information online about the benefits and safety of natural supplements, and social media influencers and health bloggers often endorse these products. This visibility and endorsement help build trust and drive market growth.

Segmental Insights

Product Type Insights

Based on the product, in 2024, the combined nutritional supplements segment emerged as the dominant segment in the Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market. combined nutritional supplements offer a holistic approach to managing PMS symptoms by including a blend of vitamins, minerals, and herbal extracts in a single product. This comprehensive formulation addresses multiple symptoms simultaneously, such as mood swings, cramps, bloating, and fatigue, providing a convenient and effective solution for women. The ease of taking one supplement that covers a wide range of nutritional needs appeals to consumers seeking simplicity and efficiency in their health routines.

The efficacy of combined supplements in delivering synergistic benefits is another driving factor. Certain nutrients work better together, enhancing each other's absorption and effectiveness. For instance, calcium and vitamin D are often combined to improve bone health, while magnesium and vitamin B6 can work together to alleviate PMS symptoms more effectively than when taken individually. This synergistic effect makes combined supplements more appealing for those looking for maximum benefit from their supplement regimen.

Indication Insights

Based on the indication segment, in 2024, the PMS (Premenstrual Syndrome) segment emerged as the dominant segment in the Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market. This dominance can be attributed to several key factors. PMS affects a substantial portion of the female population, with studies indicating that up to 75% of menstruating women experience some form of PMS during their reproductive years. This high prevalence translates into a larger target market for PMS-specific supplements, driving higher demand and market growth compared to perimenopause supplements.

The symptoms of PMS, such as mood swings, bloating, cramps, and fatigue, occur monthly, leading to a more consistent and recurrent need for relief. Women seek effective and reliable solutions to manage these symptoms, making PMS supplements a frequent purchase. In contrast, perimenopause is a transitional phase that, while significant, does not affect as broad a demographic in the same recurring manner as PMS.

There has been a notable increase in consumer awareness and education regarding PMS and its management. Public health campaigns, educational content, and the influence of social media have all contributed to heightened awareness about PMS and the benefits of supplements in managing its symptoms. This increased awareness has driven more women to proactively seek out and use PMS-specific supplements. The market has seen a surge in innovation and product development specifically targeting PMS relief. Companies are investing in research and development to create more effective formulations, incorporating natural and scientifically backed ingredients. These innovative products cater directly to the needs of women suffering from PMS, further solidifying the segment's dominance.

Regional Insights

North America emerged as the dominant region in the Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market in 2024, holding the largest market share. There is a high level of awareness and education about PMS and menstrual health in North America. Women in this region are well-informed about the symptoms of PMS and the benefits of using supplements for managing these symptoms. This heightened awareness is driven by robust public health campaigns, educational initiatives, and widespread information available through healthcare providers and digital media.

The region has a well-established and advanced healthcare infrastructure that supports the widespread availability and distribution of PMS and menstrual health supplements. Retail pharmacies, online platforms, and specialty health stores offer a broad range of products, making it easy for consumers to access and purchase these supplements.

Key Market Players

• Herbalife International of America, Inc.
• Nature's Bounty
• Amway Corp.
• GNC Holdings, LLC
• USANA Health Sciences, Inc
• GlaxoSmithKline Plc
• MetP Pharma AG
• Archer-Daniels-Midland Company
• Power Gummies
• Looni

Report Scope:

In this report, the Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market, By Product Type:

• Combined Nutritional Supplements
• Single Nutritional Supplements

Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market, By Indication:

• Perimenopause
• PMS

Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market, By Formulation:

• Capsules/Tablets
• Powder
• Softgels
• Other

Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market, By End Use:

• Pharmacies/Drug Stores
• Online Sales Channel
• Direct Sales Channel
• Others

Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market.

Available Customizations:

Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Combined Nutritional Supplements, Single Nutritional Supplements)
  • 5.2.2. By Indication (Perimenopause, PMS)
  • 5.2.3. By Formulation (Capsules/Tablets, Powder, Softgels, Other)
  • 5.2.4. By End Use (Pharmacies/Drug Stores, Online Sales Channel, Direct Sales Channel, Others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Indication
  • 6.2.3. By Formulation
  • 6.2.4. By End Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By Formulation
      • 6.3.1.2.4. By End Use
  • 6.3.2. Mexico Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By Formulation
      • 6.3.2.2.4. By End Use
  • 6.3.3. Canada Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By Formulation
      • 6.3.3.2.4. By End Use

7. Europe Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Indication
  • 7.2.3. By Formulation
  • 7.2.4. By End Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By Formulation
      • 7.3.1.2.4. By End Use
  • 7.3.2. Germany Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By Formulation
      • 7.3.2.2.4. By End Use
  • 7.3.3. United Kingdom Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By Formulation
      • 7.3.3.2.4. By End Use
  • 7.3.4. Italy Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Indication
      • 7.3.4.2.3. By Formulation
      • 7.3.4.2.4. By End Use
  • 7.3.5. Spain Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Indication
      • 7.3.5.2.3. By Formulation
      • 7.3.5.2.4. By End Use

8. Asia-Pacific Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Indication
  • 8.2.3. By Formulation
  • 8.2.4. By End Use
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By Formulation
      • 8.3.1.2.4. By End Use
  • 8.3.2. India Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By Formulation
      • 8.3.2.2.4. By End Use
  • 8.3.3. South Korea Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By Formulation
      • 8.3.3.2.4. By End Use
  • 8.3.4. Japan Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Indication
      • 8.3.4.2.3. By Formulation
      • 8.3.4.2.4. By End Use
  • 8.3.5. Australia Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Indication
      • 8.3.5.2.3. By Formulation
      • 8.3.5.2.4. By End Use

9. South America Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Indication
  • 9.2.3. By Formulation
  • 9.2.4. By End Use
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By Formulation
      • 9.3.1.2.4. By End Use
  • 9.3.2. Argentina Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By Formulation
      • 9.3.2.2.4. By End Use
  • 9.3.3. Colombia Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By Formulation
      • 9.3.3.2.4. By End Use

10. Middle East and Africa Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Indication
  • 10.2.3. By Formulation
  • 10.2.4. By End Use
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Indication
      • 10.3.1.2.3. By Formulation
      • 10.3.1.2.4. By End Use
  • 10.3.2. Saudi Arabia Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Indication
      • 10.3.2.2.3. By Formulation
      • 10.3.2.2.4. By End Use
  • 10.3.3. UAE Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Indication
      • 10.3.3.2.3. By Formulation
      • 10.3.3.2.4. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Herbalife International of America, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Nature's Bounty
• 14.3. Amway Corp.
• 14.4. GNC Holdings, LLC
• 14.5. USANA Health Sciences, Inc
• 14.6. GlaxoSmithKline Plc
• 14.7. MetP Pharma AG
• 14.8. Archer-Daniels-Midland Company
• 14.9. Power Gummies
• 14.10. Looni

15. Strategic Recommendations

16. About Us & Disclaimer